First patient enrolled in cohort combining bexobrutideg with venetoclaxInitial cohort to focus on relapsed/refractory CLL, with potential ...
Nurix Therapeutics enrolled the first patient in a Phase 1b/2 study of bexobrutideg plus venetoclax for CLL/SLL under its ...
Agreement with EU-based manufacturer expands TurboGen’s defense and civilian markets and features an initial five-year term ...
October 5, 2026, at 8:00 a.m. ET to present topline data from its OPUS-1 adult pivotal Phase 3 trial for the 31-valent ...
Nurix Therapeutics, Inc. has announced the enrollment of the first patient in its Phase 1b/2 clinical trial investigating bexobrutideg, an oral Bruton’s tyrosine kinase (BTK) degrader, in combination ...
Oftentimes, law firm marketing leaders are pitched a website redesign project based around a new look, a modern feel, and a ...
When consulting on smartphone app development, I often hear people say, 'I just want to try building it' or 'If I leave it to ...
Austin, Texas, October 6th, 2026, FinanceWireQuantum BioPharma (NASDAQ: QNTM) entered into a Study Start-Up Agreement ...
ConConAI has announced the next stage of its $CON token presale as Phase 1 and Phase 2 have sold out and Phase 3 has ...
A first-of-its-kind South Dakota State University study of 60 interviews reveals that the Northern Great Plains native seed ...
Quantum BioPharma (NASDAQ: QNTM) entered into a Study Start-Up Agreement ("SUA") with the clinical research business of Thermo Fisher Scientific to implement its Phase 2 clinical trial of ...
Oklahoma's gubernatorial candidate Cyndi Munson would issue a moratorium on data centers on her first day if elected. Mazzei ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results